ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression

ClinicalTrials.gov ID: NCT03460756

Public ClinicalTrials.gov record NCT03460756. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 2:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-blind, Placebo-controlled, Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Oral Administration of Ganaxolone in Women With Postpartum Depression

Study identification

NCT ID
NCT03460756
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Marinus Pharmaceuticals
Industry
Enrollment
84 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 48 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 27, 2017
Primary completion
Jul 4, 2019
Completion
Jul 4, 2019
Last update posted
Aug 17, 2023

2017 – 2019

United States locations

U.S. sites
33
U.S. states
15
U.S. cities
32
Facility City State ZIP Site status
Marinus Research Site Glendale California 91206
Marinus Research Site Lemon Grove California 91945
Marinus Research Site Long Beach California 90806
Marinus Research Site Oceanside California 92056
Marinus Research Site Panorama City California 91402
Marinus Research Site San Bernardino California 92408
Marinus Research Site San Marcos California 92078
Marinus Research Site Ventura California 93003
Marinus Research Site Gainesville Florida 32607
Marinus Research Site Hollywood Florida 33021
Marinus Research Site Jacksonville Florida 32216
Marinus Research Site North Miami Florida 33161
Marinus Research Site Atlanta Georgia 30328
Marinus Research Site Atlanta Georgia 30331
Marinus Research Site Decatur Georgia 30030
Marinus Research Site Marietta Georgia 30060
Marinus Research Site Idaho Falls Idaho 83404
Marinus Research Site Hoffman Estates Illinois 60169
Marinus Research Site Leawood Kansas 66206
Marinus Research Site Wichita Kansas 67226
Marinus Research Site Flowood Mississippi 39232
Marinus Research Site Las Vegas Nevada 89102
Marinus Research Site Albuquerque New Mexico 87102
Marinus Research Site Raleigh North Carolina 27612
Marinus Research Site Englewood Ohio 45322
Marinus Research Site Downingtown Pennsylvania 19335
Marinus Research Site Media Pennsylvania 19063
Marinus Research Site Houston Texas 77058
Marinus Research Site Irving Texas 75062
Marinus Research Site League City Texas 77573
Marinus Research Site San Antonio Texas 78229
Marinus Research Site Orem Utah 84058-4939
Marinus Research Site Richmond Virginia 23298

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03460756, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 17, 2023 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03460756 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →